Why we're engaging with the AI Airlock
HRA describes its engagement with MHRA's AI Airlock, a regulatory sandbox for exploring emerging AI healthcare technologies safely and ethically.
UK Health Research Authority · UK
Source
UK Health Research Authority
Regulation
Category
Type · Breadth
Date
UK Health Research Authority: response to new guidance on safeguarding UK human genomic data
2 Jul 2026
UK Health Research Authority · UKNew two-year plan to support safe use of AI in UK health research
29 May 2026
UK Health Research Authority · UKMeet our volunteers: an interview with Joe Walsh
Joe Walsh is a retired chartered engineer and has been a Research Ethics Committee (REC) member for almost a decade. Alongside his role as a member, Joe also volunteers for local charities. Here he shares his experien...
UK Health Research Authority · UKActing on feedback: improving our services and ways of working
Becky Purvis, Director of Policy and Partnerships We want to make sure that everyone who volunteers, gets involved with our work or uses our services has the best experience possible. These individuals are best placed...
UK Health Research Authority · UKHRA response to UKRI's five-year strategy
UK Research and Innovation (UKRI) has today published its newfive-year strategy, setting out how it will make the most of the Government's record £38.6 billion investment in research and innovation to advance knowledg...
UK Health Research Authority · UKMeet our volunteers: an interview with Gareth Tudor-Williams
Our volunteers generously give their time and expertise to support health and social care research across the UK. By reviewing research studies, they help ensure research is ethical, safe and centred on participants, ...
UK Health Research Authority · UKHealth Research Authority response to Care Quality Commission assessment framework consultation
6 Jul 2026
UK Health Research Authority · UKHealth Research Authority response to MHRA rare disease therapies regulatory framework consultation
HRA supports MHRA's proposed regulated pathway for rare disease therapies to enable earlier patient access while generating safety and effectiveness evidence.
UK Health Research Authority · UKHealth Research Authority 2026–27 business plan: delivering faster, simpler, trusted research in the UK
29 May 2026
UK Health Research Authority · UKNew report shows levels of public involvement in health and social care research in the UK remains high
28 May 2026
UK Health Research Authority · UKHow a more joined-up approach can strengthen the UK's research system
27 May 2026
UK Health Research Authority · UKMeet our volunteers: an interview with Professor Ben Gibbison
29 May 2026
UK Health Research Authority · UKMeet our volunteers: an interview with Dr Manish Saxena
29 May 2026
UK Health Research Authority · UKEbola vaccine fast-track review
UK Health Research Authority conducting expedited review of Ebola vaccine.
UK Health Research Authority · UKInnovative fridge-free vaccine clinical trial results announced
Phase 1 clinical trial results for SPVX02, a fridge-free tetanus-diphtheria vaccine, have been announced following HRA approval in February 2025.
UK Health Research Authority · UKUK HRA: Legal challenge to PATHWAYS Trial approval rejected by High Court
High Court rejected a legal challenge to HRA and MHRA approval of the PATHWAYS Trial, a clinical trial of puberty-suppressing medication in young people with gender incongruence.
UK Health Research Authority · UK
Showing 23 of 23 tracked updates
Health-tech only